Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations.
Alimena G, Breccia M, Latagliata R, Grammatico S, Matturro A, Capria S, De Propris MS, Diverio D, Meloni G. Alimena G, et al. Among authors: de propris ms. Leuk Res. 2009 Aug;33(8):e134-6. doi: 10.1016/j.leukres.2009.02.018. Epub 2009 Mar 14. Leuk Res. 2009. PMID: 19286256 No abstract available.
Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.
Alimena G, Breccia M, Mancini M, Diverio D, Nanni M, De Propris MS, Cimino G, Pane F, Mandelli F. Alimena G, et al. Among authors: de propris ms. Leukemia. 2005 Feb;19(2):287-9. doi: 10.1038/sj.leu.2403584. Leukemia. 2005. PMID: 15538403 No abstract available.
Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
Breccia M, Santopietro M, Cannella L, Federico V, Loglisci G, Serrao A, Petrucci L, Salaroli A, Nanni M, De Propris MS, Diverio D, Alimena G. Breccia M, et al. Among authors: de propris ms. Leuk Res. 2011 Jun;35(6):e91-2. doi: 10.1016/j.leukres.2011.01.026. Epub 2011 Feb 11. Leuk Res. 2011. PMID: 21316103 No abstract available.
Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study.
Cannizzo E, Raia M, De Propris MS, Triolo A, Scarpati B, Marfia A, Stacchini A, Buccisano F, Lanza F, Regazzoli A, Michelutti A, Cesaro S, Conte CA, Vanelli L, Tedone E, Omedè P, Ciriello MM, Caporale R, Catinella V, Pantano G, De Rosa C, Lo Pardo C, Poletti G, Ulbar F, Pavanelli MC, Del Pup L, Ottaviano V, Santonocito AM, Bartocci C, Boscaro E, Arras M, Amodeo R, Mestice A, Oliva B, Ferrari L, Statuto T, D'Auria F, Pianezze G, Tanca D, Visconte F, Rubba F, Musto P, Geuna M, Gatti A, Brando B, Del Vecchio L. Cannizzo E, et al. Among authors: de propris ms, de rosa c. Ann Hematol. 2019 May;98(5):1083-1093. doi: 10.1007/s00277-019-03644-8. Epub 2019 Mar 13. Ann Hematol. 2019. PMID: 30868306 Clinical Trial.
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma with or without antiretroviral therapy during antineoplastic agents.
Gastaldi R, Martino P, Gentile G, De Propris MS, Pirillo MF, De Vellis A, Mandelli F. Gastaldi R, et al. Among authors: de vellis a, de propris ms. Ann Oncol. 2003 Dec;14(12):1792-4. doi: 10.1093/annonc/mdg484. Ann Oncol. 2003. PMID: 14630687 Free article. Clinical Trial. No abstract available.
Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor.
Gastaldi R, Martino P, Gentile G, Picardi V, De Propris MS, Pirillo MF, De Vellis A, Mandelli F. Gastaldi R, et al. Among authors: de vellis a, de propris ms. Ann Oncol. 2002 Jul;13(7):1158-60. doi: 10.1093/annonc/mdf239. Ann Oncol. 2002. PMID: 12176798 No abstract available.
115 results